| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;105:1928.)
© 2002 American Heart Association, Inc.
Clinical Investigation and Reports |
From Weill Medical College of Cornell University, New York, NY (J.N.B., V.P., M.J.R., J.E.L., R.B.D.); Aberdeen Area Tribal Chairmens Health Board, Rapid City, SD (T.K.W.); the University of Oklahoma School of Public Health Services, Oklahoma City (E.T.L.); the Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, Bethesda, Md (R.R.F.); and Medstar Research Institute, Washington, DC (B.V.H.).
Correspondence to Jonathan N. Bella, MD, Division of Cardiology (12th Floor), Bronx-Lebanon Hospital Center/Albert Einstein College of Medicine, 1650 Grand Concourse, Bronx, NY 10457. E-mail jonnbella{at}earthlink.net
Background With aging, left ventricular filling tends to decrease in early diastole, reducing the mitral ratio of peak early to late diastolic filling velocity (E/A). However, the prognostic significance of low or high E/A in older adults remains to be elucidated in population-based samples.
Methods and Results Doppler echocardiograms were analyzed in 3008 American Indian participants in the second Strong Heart Study examination who had no more than mild mitral or aortic regurgitation. Participants were followed for a mean of 3 years after Doppler echocardiography to assess risks of all-cause and cardiac death associated with E/A <0.6 or >1.5; 2429 (81%) participants had normal E/A ratio, 490 (16%) had E/A <0.6, and 89 (3%) had E/A >1.5. All-cause mortality was higher with E/A <0.6 or E/A >1.5 (12% and 13% versus 6%), as was cardiac mortality (4.5% and 6.5% versus 1.6%; both P<0.001). Adjusting for age, sex, body mass index, systolic blood pressure, HDL and LDL cholesterol, smoking, hypertension, diabetes, coronary heart disease, left ventricular hypertrophy, and low ejection fraction (<40%), the relative risk of all-cause death with E/A >1.5 was 1.73 (95% CI, 0.99 to 3.03; P=0.05); the relative risk of cardiac death was 2.8 (95% CI, 1.19 to 6.75; P<0.05). E/A <0.6 was not independently associated with increased all-cause or cardiac mortality (P=0.19 and 0.31, respectively) after adjusting for covariates.
Conclusions In a population-based sample of middle-aged and elderly adults, mitral E/A >1.5 at baseline Doppler echocardiography is associated with 2-fold increased all-cause and 3-fold increased cardiac mortality independent of covariates; mitral E/A <0.6 was also associated with 2-fold increased all-cause and cardiac mortality but not independent of covariates.
Key Words: epidemiology mortality echocardiography diastole aging
This article has been cited by other articles:
![]() |
R. M. Wilson, D. S. De Silva, K. Sato, Y. Izumiya, and F. Sam Effects of Fixed-Dose Isosorbide Dinitrate/Hydralazine on Diastolic Function and Exercise Capacity in Hypertension-Induced Diastolic Heart Failure Hypertension, September 1, 2009; 54(3): 583 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kuznetsova, L. Herbots, B. Lopez, Y. Jin, T. Richart, L. Thijs, A. Gonzalez, M.-C. Herregods, R. H. Fagard, J. Diez, et al. Prevalence of Left Ventricular Diastolic Dysfunction in a General Population Circ Heart Fail, March 1, 2009; 2(2): 105 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Nagueh, C. P. Appleton, T. C. Gillebert, P. N. Marino, J. K. Oh, O. A. Smiseth, A. D. Waggoner, F. A. Flachskampf, P. A. Pellikka, and A. Evangelisa Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography Eur J Echocardiogr, March 1, 2009; 10(2): 165 - 193. [Full Text] [PDF] |
||||
![]() |
G. Grassi, G. Seravalle, F. Quarti-Trevano, R. Dell'Oro, F. Arenare, D. Spaziani, and G. Mancia Sympathetic and Baroreflex Cardiovascular Control in Hypertension-Related Left Ventricular Dysfunction Hypertension, February 1, 2009; 53(2): 205 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mahmood, A. Christie, and R. Matyal Transesophageal Echocardiography and Noncardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2008; 12(4): 265 - 289. [Abstract] [PDF] |
||||
![]() |
H. Von Bibra, M. Diamant, P. G Scheffer, T. Siegmund, and P.-M. Schumm-Draeger Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart disease Diabetes and Vascular Disease Research, November 1, 2008; 5(4): 310 - 318. [Abstract] [PDF] |
||||
![]() |
C. Jarnert, A. Melcher, K. Caidahl, H. Persson, L. Ryden, and M. J. Eriksson Left atrial velocity vector imaging for the detection and quantification of left ventricular diastolic function in type 2 diabetes Eur J Heart Fail, November 1, 2008; 10(11): 1080 - 1087. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ishizu, Y. Seo, S. Kawano, S. Watanabe, T. Ishimitsu, and K. Aonuma Stratification of impaired relaxation filling patterns by passive leg lifting in patients with preserved left ventricular ejection fraction Eur J Heart Fail, November 1, 2008; 10(11): 1094 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Patel, V. J.B. Robinson, R. B. Arteaga, and J. W. Thornton Diastolic Filling Parameters Derived from Myocardial Perfusion Imaging Can Predict Left Ventricular End-Diastolic Pressure at Subsequent Cardiac Catheterization J. Nucl. Med., May 1, 2008; 49(5): 746 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. de Simone, J. S. Gottdiener, M. Chinali, and M. S. Maurer Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study Eur. Heart J., March 2, 2008; 29(6): 741 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Siegmund, P.-M. Schumm-Draeger, D. Antoni, and H. Von Bibra Beneficial effects of ramipril on myocardial diastolic function in patients with type 2 diabetes mellitus, normal LV systolic function and without coronary artery disease: a prospective study using tissue Doppler Diabetes and Vascular Disease Research, December 1, 2007; 4(4): 358 - 364. [Abstract] [PDF] |
||||
![]() |
S. M. Bierig, A. Ryan, A. Ziaee, L. Kociolek, J. Simon, S. Herrmann, and A. J. Labovitz Serial changes in systolic and diastolic echocardiographic indices as predictors of outcome in patients with decreased left ventricular ejection fraction Eur J Echocardiogr, October 1, 2007; 8(5): 369 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Gaasch and W. C. Little Assessment of Left Ventricular Diastolic Function and Recognition of Diastolic Heart Failure Circulation, August 7, 2007; 116(6): 591 - 593. [Full Text] [PDF] |
||||
![]() |
J. N. Kirkpatrick, M. A. Vannan, J. Narula, and R. M. Lang Echocardiography in Heart Failure: Applications, Utility, and New Horizons J. Am. Coll. Cardiol., July 31, 2007; 50(5): 381 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members:, G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A. M. Heagerty, S. E. Kjeldsen, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur. Heart J., June 11, 2007; (2007) ehm236v1. [Full Text] [PDF] |
||||
![]() |
C. Avgeropoulou, A. Illmann, P.-M. Schumm-Draeger, J. Kallikazaros, and H. Von Bibra Assessment of arterio-ventricular coupling by tissue Doppler and wave intensity in type 2 diabetes The British Journal of Diabetes & Vascular Disease, November 1, 2006; 6(6): 271 - 278. [Abstract] [PDF] |
||||
![]() |
M. Galderisi Diastolic Dysfunction and Diabetic Cardiomyopathy: Evaluation by Doppler Echocardiography J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1548 - 1551. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Eryonucu, N. Guler, U. Guntekin, and M. Tuncer Comparison of the Effects of Nitroglycerin and Nitroprusside on Transmitral Doppler Flow Parameters in Patients with Hypertensive Urgency Ann. Pharmacother., June 1, 2005; 39(6): 997 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. W. Nielsen, A. Sajedieh, F. Petersen, and J. Fischer Hansen Value of left ventricular filling parameters to predict mortality and functional class in patients with heart disease from the community Eur J Echocardiogr, March 1, 2005; 6(2): 85 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Von Bibra, I. S Thrainsdottir, A. Hansen, V. Dounis, K. Malmberg, and L. Ryden Tissue Doppler imaging for the detection and quantitation of myocardial dysfunction in patients with type 2 diabetes mellitus Diabetes and Vascular Disease Research, February 1, 2005; 2(1): 24 - 30. [Abstract] [PDF] |
||||
![]() |
D. J. Campbell, M. Woodward, J. P. Chalmers, S. A. Colman, A. J. Jenkins, B. E. Kemp, B. C. Neal, A. Patel, and S. W. MacMahon Prediction of Heart Failure by Amino Terminal-pro-B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease Hypertension, January 1, 2005; 45(1): 69 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Beinart, V. Boyko, E. Schwammenthal, R. Kuperstein, A. Sagie, H. Hod, S. Matetzky, S. Behar, M. Eldar, and M. S. Feinberg Long-term prognostic significance of left atrial volume in acute myocardial infarction J. Am. Coll. Cardiol., July 21, 2004; 44(2): 327 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Redfield, R. J. Rodeheffer, S. J. Jacobsen, D. W. Mahoney, K. R. Bailey, and J. C. Burnett Jr Plasma Brain Natriuretic Peptide to Detect Preclinical Ventricular Systolic or Diastolic Dysfunction: A Community-Based Study Circulation, June 29, 2004; 109(25): 3176 - 3181. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. McGavock, S. Mandic, I. Vonder Muhll, R. Z. Lewanczuk, H. A. Quinney, D. A. Taylor, R. C. Welsh, and M. Haykowsky Low Cardiorespiratory Fitness Is Associated With Elevated C-Reactive Protein Levels in Women With Type 2 Diabetes Diabetes Care, February 1, 2004; 27(2): 320 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nodari, M. Metra, and L. D. Cas {beta}-Blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol Eur J Heart Fail, October 1, 2003; 5(5): 621 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, G. Azhar, M. C. Furr, Y. Zhong, and J. Y. Wei Model of functional cardiac aging: young adult mice with mild overexpression of serum response factor Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R552 - R560. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Muiesan, M. Lupia, M. Salvetti, C. Grigoletto, N. Sonino, M. Boscaro, E. A. Rosei, F. Mantero, and F. Fallo Left ventricular structural and functional characteristics in Cushing's syndrome J. Am. Coll. Cardiol., June 18, 2003; 41(12): 2275 - 2279. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Liu, D. C. Robbins, V. Palmieri, J. N. Bella, M. J. Roman, R. Fabsitz, B. V. Howard, T. K. Welty, E. T. Lee, and R. B. Devereux Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: The Strong Heart Study J. Am. Coll. Cardiol., June 4, 2003; 41(11): 2022 - 2028. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Peterson, M. R. Rinder, K. B. Schechtman, R. J. Spina, K. L. Glover, D. T. Villareal, and A. A. Ehsani Peak exercise stroke volume: associations with cardiac structure and diastolic function J Appl Physiol, March 1, 2003; 94(3): 1108 - 1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Redfield, S. J. Jacobsen, J. C. Burnett Jr, D. W. Mahoney, K. R. Bailey, and R. J. Rodeheffer Burden of Systolic and Diastolic Ventricular Dysfunction in the Community: Appreciating the Scope of the Heart Failure Epidemic JAMA, January 8, 2003; 289(2): 194 - 202. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |